Skylight Health Group - CEO, Prad Sekar.
CEO, Prad Sekar.
Source: Skylight Health Group
  • Skylight Health Group (SLHG) has closed its previously announced non-brokered private placement for gross proceeds of $2,355,000
  • The company issued 2,355 units of unsecured convertible debentures at $1,000 per unit
  • Each debenture will bear an annual interest rate of 8 per cent, paid quarterly in shares
  • Each debenture shall be convertible into 1,111 common shares at C$0.90 and 1,111 share purchase warrants
  • All securities issued are subject to a statutory hold period expiring on December 18, 2022
  • Skylight Health operates a U.S. multi-state primary care health network providing sub-specialty, allied health and laboratory/diagnostic testing
  • Skylight Health Group Inc. (SLHG)is down 4.55 per cent on the day, trading at C$0.84 per share at 3:30 pm ET

Skylight Health Group (SLHG) has closed its previously announced non-brokered private placement for gross proceeds of $2,355,000.

The company issued 2,355 units of unsecured convertible debentures at $1,000 per unit.

Prad Sekar, CEO & Co-Founder of Skylight Health, remarked on the successful capital raise.

“We have a strong history of being diligent in our capital raising to ensure minimal dilution, and this cash injection gives us a buffer to get us comfortably to cash flow positivity.”

Each debenture will bear an annual interest rate of 8 per cent, paid quarterly in shares, and shall have a maturity date of February 15, 2025.

Each debenture shall be convertible into 1,111 common shares at C$0.90. Each debenture holder will also receive 1,111 share purchase warrants. Each warrant entitles the holder to purchase one common share for a period 24 months.

The proceeds from the offering will be used for general working capital purposes.

The company paid finder’s fees consisting of a cash payment of $42,000 and 60,778 finders’ warrants.

All securities issued are subject to a statutory hold period expiring on December 18, 2022.

Skylight Health operates a U.S. multi-state primary care health network providing sub-specialty, allied health and laboratory/diagnostic testing.

Skylight Health Group Inc. (SLHG)is down 4.55 per cent on the day, trading at C$0.84 per share at 3:30 pm ET.


More From The Market Online

PharmAla Biotech launches educational portal for MDMA

PharmAla Biotech (CSE:MDMA) launches its Prescribers Portal for medical practitioners to learn more about MDMA.

Cancer-fighting pharma stock eyes 2027 regulatory approval

Theralase Technologies (TSXV:TLT), a cancer-fighting pharma stock, expands its team with two clinical research associates.

PharmaDrug-PharmaTher Holdings JV submits clinical, regulatory package

Sairiyo Therapeutics, a PharmaDrug (CSE:PHRX) and PharmaTher Holdings (CSE:PHRM) joint venture, pursues a human clinical study in Australia.